摘要
目的:探讨体质量指数与甲状腺癌组织瘦素(Leptin)表达水平的相关性,为临床诊断及治疗分化型甲状腺癌提供依据。方法:选择分化型甲状腺癌患者167例,根据体质量指数分为体重正常组(n=64)、超重组(n=47)和肥胖组(n=56),观察各组的甲状腺组织Leptin及其受体(OB-R)表达水平。结果:正常组的肿瘤大小以<1cm为主,而肥胖组则以≥1cm居多(P<0.05);正常组肿瘤分期I、Ⅱ期比例居多,肥胖组以Ⅲ、Ⅳ期为主(P<0.05);三组患者的Leptin、OB-R表达水平随着患者体质量指数的增加而逐渐升高(P<0.05);甲状腺癌患者体质量指数与Leptin表达水平呈正相关。结论:Leptin与甲状腺癌的发生、进展密切相关,同时Leptin与患者体质量指数密切相关。
Objective:To investigate the correlation between body mass index and Leptin expression in thyroid cancer of patients with differentiated thyroid carcinoma. Methods :There were 167 patients with differentiated thyroid carcinoma were selected, according to body mass index, they were divided into normal group (n = 64), over group (n = 47 ) and obesity group ( n = 56 ). The changes of Leptin expression level in each group was observed. Results : The tumor size of normal group were dominated by 〈 1 cm, that of obese group were dominated by ≥ I cm( P 〈 0.05 ). The percentage of Ⅰ and Ⅱ phase tumor stage in normal group was major, and the percentage of Ⅲ, Ⅳ stage in obesity group was major( P 〈 0.05 ). With patients' body mass index increasing in there group, they increased gradually (P 〈 0.05 ). Conclusion:There is a close correlation between Leptin and thyroid carcinogenesis. Obesity may promote the combination of Leptin and OB - R through a variety of mechanisms, activating related signal pathway in thyroid tissue, eventually lead to thyroid cancer.
出处
《现代肿瘤医学》
CAS
2016年第1期44-46,共3页
Journal of Modern Oncology
关键词
分化型甲状腺癌
体质量指数
瘦素
differentiated thyroid cancer, body mass index, Leptin